BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33255665)

  • 21. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.
    Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG
    Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Sensitive TRBC1-Based Flow Cytometric Assessment of T-Cell Clonality in Tαβ-Large Granular Lymphocytic Leukemia.
    Muñoz-García N; Morán-Plata FJ; Villamor N; Lima M; Barrena S; Mateos S; Caldas C; van Dongen JJM; Orfao A; Almeida J
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations.
    Tanahashi T; Sekiguchi N; Matsuda K; Takezawa Y; Ito T; Kobayashi H; Ichikawa N; Nishina S; Senoo N; Sakai H; Nakazawa H; Ishida F
    Leuk Res; 2016 Jun; 45():8-13. PubMed ID: 27064362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients.
    Barilà G; Teramo A; Calabretto G; Vicenzetto C; Gasparini VR; Pavan L; Leoncin M; Vedovato S; Frigo AC; Facco M; Semenzato G; Zambello R
    Leukemia; 2020 Apr; 34(4):1116-1124. PubMed ID: 31740810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
    Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
    Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options.
    Calabretto G; Teramo A; Barilà G; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single center.
    Ai K; Li M; Wu P; Deng C; Huang X; Ling W; Xu R; Geng S; Sun Q; Weng J; Du X
    Am J Cancer Res; 2021; 11(4):1616-1631. PubMed ID: 33948377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL).
    Fischer L; Hummel M; Burmeister T; Schwartz S; Thiel E
    Hematol Oncol; 2006 Jun; 24(2):78-85. PubMed ID: 16598823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How I diagnose large granular lymphocytic leukemia.
    Shi M; Morice WG
    Am J Clin Pathol; 2024 Jun; ():. PubMed ID: 38823032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia.
    Olson KC; Kulling PM; Olson TL; Tan SF; Rainbow RJ; Feith DJ; Loughran TP
    Cancer Biol Ther; 2017 May; 18(5):290-303. PubMed ID: 27715403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Large granular lymphocytic leukemia and its association with immune dysregulation].
    Ishida F
    Rinsho Ketsueki; 2023; 64(8):791-798. PubMed ID: 37673632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
    Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
    Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclonal STAT3 mutations solidify clonal dominance.
    Kerr CM; Clemente MJ; Chomczynski PW; Przychodzen B; Nagata Y; Adema V; Visconte V; Lichtin AE; Mustjoki S; Radivoyevitch T; Sekeres MA; Maciejewski JP
    Blood Adv; 2019 Mar; 3(6):917-921. PubMed ID: 30898763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of a STAT3 mutated NK clone in LGL leukemia.
    Yan Y; Olson TL; Nyland SB; Feith DJ; Loughran TP
    Leuk Res Rep; 2015; 4(1):4-7. PubMed ID: 25709890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation of large granular lymphocytic leukemias: data from the laboratory of hematology at Nancy University Hospital, France].
    Guisnel C; Lesesve JF; Gérard D; Salignac S; Muller M; Feugier P; Broséus J; Latger-Cannard V
    Ann Biol Clin (Paris); 2022 Feb; 80(1):47-54. PubMed ID: 35118947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.
    Oshimi K
    Intern Med; 2017; 56(14):1759-1769. PubMed ID: 28717070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
    PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations.
    Olson KC; Moosic KB; Jones MK; Larkin PMK; Olson TL; Toro MF; Fox TE; Feith DJ; Loughran TP
    Cancer Med; 2020 Sep; 9(18):6533-6549. PubMed ID: 32710512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.
    Teramo A; Binatti A; Ciabatti E; Schiavoni G; Tarrini G; Barilà G; Calabretto G; Vicenzetto C; Gasparini VR; Facco M; Petrini I; Grossi R; Pisanti N; Bortoluzzi S; Falini B; Tiacci E; Galimberti S; Semenzato G; Zambello R
    Nat Commun; 2022 Jun; 13(1):3298. PubMed ID: 35676278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.
    Poullot E; Zambello R; Leblanc F; Bareau B; De March E; Roussel M; Boulland ML; Houot R; Renault A; Fest T; Semenzato G; Loughran T; Lamy T
    Ann Oncol; 2014 Oct; 25(10):2030-2035. PubMed ID: 25096606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.